RA Anupam Bajpai

@anupam.4727

Indore

2+ Years of experience

SEBI Registration INH000016339

Anupam Bajpai a SEBI Registered Research Analyst (INH000016339). Provide recommendations on equity cash, option, and future classes for technical and fundamental analysis.All views shared are for educational purposes only and should not be treated as investment advice.

Trade Ideas

Opinions

184

Followers

114k

Expertise

Quantitative

Growth

Technical

Index Strategies

Market Commentary

Futures & Options

Technical Analysis

Trade Facts

Total Trades

Missed Trades

Profit Trades

Accuracy

Ask me Anything

Got a question? Ask me and I will answer it. Stay curious, stay hungry!

Posts

shared an insight ⚡️ 17th Nov

nifty weekly outlook

Technical Highlights Moving Averages: Nifty is trading firmly above the 20, 50, 100, and 200 DMAs, confirming a strong trending market and steady buying strength. RSI: RSI stays in the 60–65 zone, indicating healthy bullish momentum without entering overbought territory. This supports further upside potential. Bollinger Bands: Price action is near the upper half of the band, with the upper band around 26,090–26,120 acting as the immediate resistance. A breakout and close above this zone will signal a strong continuation move. Key Levels: Resistance: 26,100 – breakout may push Nifty toward 26,300–26,500. Support: 25,600 – must be protected for the bullish trend to remain intact. Sector Focus Banking: Strong chart structure and leadership; expected to drive Nifty higher. IT: Stable upward momentum; supports overall index strength. Metals: High relative strength with continuation signals on charts. Stocks to Watch

SBIN

: Strong trend, trading well above key MAs; likely to participate in the breakout.

JIOFIN

: Sustained accumulation with improving price structure.

MCX

: Momentum building on the back of strong commodity activity. Conclusion Nifty maintains a positive bias above 25,600. A decisive breakout above 26,100 will confirm the next upside leg toward 26,300–26,500. Focus remains on Banking, IT, and Metal sectors for leadership.

1092

shared an insight ⚡️ 13th Nov

GODREJPROP

– Technical and Fundamental Analysis

GODREJPROP

is currently trading around ₹2,190 and continues to reflect strength across both technical and fundamental parameters. On the fundamental side, the company has reported strong financial performance with record quarterly profits and a healthy rise in bookings and collections. Its asset-light model, large project pipeline, and presence across major cities like Mumbai, Bengaluru, NCR, and Pune provide long-term growth visibility. The balance sheet remains comfortable with moderate leverage, while consistent demand in the real-estate sector further supports its outlook. However, the valuation is slightly elevated with a P/E around 42x, suggesting that much of the near-term optimism is already priced in. From a technical perspective, the stock shows a firm uptrend, trading above all key moving averages (20, 50, 100, and 200 DMA). This alignment indicates sustained buying momentum and positive sentiment among investors. The RSI near 53 signals stable momentum without being overbought, while the price movement along the upper Bollinger Band suggests continued strength with minor consolidation possible before the next leg up. Key support levels are placed near ₹2,120–₹2,150, providing a strong base, while resistance is seen near ₹2,360, which if crossed, could trigger further upside. Overall View: Both technical and fundamental factors support a bullish outlook for Godrej Properties. Continued growth in sales and stable sector demand strengthen confidence in its uptrend. Upside Target: ₹2,345

763

shared an insight ⚡️ 13th Nov

!Aurobindo Pharma: Strong Uptrend Backed by Solid Fundamentals and Bullish Momentum

AUROPHARMA

is currently trading around ₹1,216 and continues to exhibit strength across both fundamental and technical parameters. On the fundamental front, the company maintains a healthy financial profile with a P/E ratio of around 20x and a low debt-to-equity ratio of 0.22, reflecting strong balance sheet stability. Its diversified portfolio in formulations and active pharmaceutical ingredients (APIs), along with a significant global presence, supports steady revenue growth. From a technical perspective, Aurobindo Pharma has been trading firmly above its key moving averages — the 20, 50, 100, and 200-day lines — which confirms a sustained uptrend. The alignment of these moving averages points toward strong underlying momentum and investor confidence. The RSI (14) is hovering near 82, indicating strong bullish momentum, though it also places the stock in overbought territory, hinting at the possibility of brief consolidation or sideways movement before the next leg up. The price is currently positioned near the upper Bollinger Band, signaling continued strength but also suggesting that it may temporarily pause to absorb recent gains. In terms of key levels, support is seen around ₹1,150–₹1,180, coinciding with the short-term moving averages, while the immediate resistance lies near ₹1,350, which aligns with the upper end of the recent trading range. The overall chart structure remains positive, with higher highs and higher lows indicating trend continuation. Overall Outlook: Both the technical setup and fundamental strength point toward a bullish bias in Aurobindo Pharma. The trend remains upward with healthy participation and improving fundamentals. While short-term volatility cannot be ruled out due to overbought readings, the broader outlook remains positive. Upside Target: ₹1,260

1139

What are the top stock recommendations by RA Anupam Bajpai?

RA Anupam Bajpai regularly shares stock views and market analysis on StockGro. Some of the stocks they have recently shared views on include SBIN, JIOFIN, MCX, GODREJPROP and AUROPHARMA. Explore RA Anupam Bajpai's complete list of posts and trade views on their StockGro profile.

How can I follow RA Anupam Bajpai's latest investment insights?

You can follow RA Anupam Bajpai's latest investment insights, stock recommendations, and market analysis on StockGro App. Additionally, you can check their detailed stock analysis reports in the StockGro blog section.

What is RA Anupam Bajpai's investment strategy?

RA Anupam Bajpai follows a data-driven, research-backed investment strategy focused on maximizing returns while managing risk. Their approach includes fundamental and technical analysis, portfolio diversification, and sectoral trends to identify high-potential stocks.

How long has RA Anupam Bajpai been a SEBI-registered Research Analyst (RA)?

RA Anupam Bajpai has been a SEBI-registered Research Analyst and have 2+ Years of experience. With extensive experience in stock market analysis and investment research, they have guided investors in making informed and profitable decisions.

Where can I see RA Anupam Bajpai's past performance and stock picks?

You can check RA Anupam Bajpai's past stock recommendations, success rate, and investment insights on their StockGro profile. Their historical stock picks reflect a track record of strategic investment decisions based on thorough research.

How can I contact RA Anupam Bajpai for stock market advice?

For stock market guidance from RA Anupam Bajpai, you can connect through their StockGro profile. Some RAs may also provide personalized investment consultations based on their availability and SEBI regulations.

What is RA Anupam Bajpai's track record in predicting market movements?

RA Anupam Bajpai has a proven track record of accurate market analysis and trend predictions. By analyzing economic indicators, market sentiment, and technical charts, they have consistently helped investors make well-timed investment decisions.

What is the SEBI Registration number for RA Anupam Bajpai?

RA Anupam Bajpai is a SEBI-registered Research Analyst with the SEBI Registration INH000016339. This ensures that their investment recommendations comply with SEBI's regulatory framework for investor protection and financial advisory standards.

Be Financially Free with StockGro